PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsMethylphenidate hydrochloride
Methylphenidate hydrochloride
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
513 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Attention deficit disorder with hyperactivityD001289EFO_0003888F9013316011082284
HyperkinesisD006948——519436758185
Healthy volunteers/patients———13125829
Cocaine-related disordersD019970—F147611216
Substance-related disordersD019966EFO_0003890F132224515
Brain injuriesD001930—S06.925—3110
DementiaD003704EFO_0003862F03—126110
DepressionD003863—F33.91242210
ApathyD057565——121329
Cognitive dysfunctionD060825—G31.84—31429
Show 68 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
FatigueD005221—R53.8321012—223
NeoplasmsD009369—C80147—313
Multiple sclerosisD009103EFO_0003885G35132——5
SclerosisD012598——132——5
Prostatic neoplasmsD011471—C61—41——4
Disorders of excessive somnolenceD006970—G47.1—21—24
DyssomniasD020920———21—13
ParasomniasD020447—G47.5—21—13
Opioid-related disordersD009293EFO_0005611F11221——3
Mood disordersD019964EFO_0004247F30-F39111——3
Show 24 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Sleep wake disordersD012893—G47—2——13
Tobacco use disorderD014029—F1711——13
Addictive behaviorD016739EFO_0004347—11——23
Consciousness disordersD003244——21———2
Congenital abnormalitiesD000013EFO_0003915Q89.9—1——12
Delayed emergence from anesthesiaD055191——21———2
HypersensitivityD006967EFO_0003785T78.40—1——12
Feeding and eating disordersD001068—F50—1——12
SleepinessD000077260—R40.0—1——12
BulimiaD002032—F50.2—1———1
Show 17 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Impulsive behaviorD007175——2———13
Borderline personality disorderD001883—F60.31———12
Personality disordersD010554—F60.61———12
Psychotic disordersD011618—F20.811———12
HypotensionD007022EFO_0005251I951————1
Pure autonomic failureD054970——1————1
Orthostatic hypotensionD007024—I95.11————1
PsilocybeD055391——1————1
ComaD003128—R40.21————1
MotivationD009042——1————1
Show 6 more
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HivD006678—O98.7————11
Memory consolidationD000069077——————11
Heat stress disordersD018882—T67.2————11
Palliative careD010166——————11
Motor activityD009043EFO_0003940—————11
Cardiovascular diseasesD002318EFO_0000319I98————11
Long qt syndromeD008133HP_0001657I45.81————11
Congenital heart defectsD006330—Q24.9————11
Inborn genetic diseasesD030342EFO_0000508—————11
Heart diseasesD006331EFO_0003777I51.9————11
Show 44 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
6,122 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use